Harmony Biosciences Holdings (HRMY) — Financial Flexibility Index
Harmony Biosciences Holdings (HRMY) has a Financial Flexibility Index of 0.25x as of June 2026. Free cash flow of $92.43 Million (operating CF $92.43 Million minus capex $0.00) represents 0% of total liabilities ($373.84 Million). Check how aggressively does Harmony Biosciences Holdings reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Harmony Biosciences Holdings Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Harmony Biosciences Holdings across 8 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Harmony Biosciences Holdings.
Annual Financial Flexibility Index for Harmony Biosciences Holdings (2018–2025)
Year-by-year free cash flow to debt coverage for Harmony Biosciences Holdings. Explore Harmony Biosciences Holdings (HRMY) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.87x | $348.51 Million | $348.20 Million | $401.41 Million | ▲ +33.6% |
| 2024 | 0.65x | $220.97 Million | $219.82 Million | $340.05 Million | ▲ +1.9% |
| 2023 | 0.64x | $219.70 Million | $219.39 Million | $344.46 Million | ▲ +19.5% |
| 2022 | 0.53x | $144.64 Million | $144.47 Million | $271.03 Million | ▲ +33.3% |
| 2021 | 0.40x | $98.86 Million | $98.56 Million | $246.94 Million | ▲ +13534.9% |
| 2020 | 0.00x | $-983.00K | $-2.98 Million | $329.89 Million | ▲ +99.5% |
| 2019 | -0.64x | $-75.29 Million | $-75.44 Million | $118.29 Million | ▲ +86.8% |
| 2018 | -4.83x | $-37.46 Million | $-38.80 Million | $7.75 Million | — |